Contact inhibition of proliferation (CIP) is a key mechanism that transduces the cell density status of tissue and 22 organs into a unique transcriptional program by translocating YAP between the nucleus and the cytoplasm.
Introduction

2
The capacity of cells to regulate their proliferation in response to the extracellular environment is a fundamental 3 requirement for the organization and maintenance of tissues and organs in multicellular organisms. Contact 4 inhibition of proliferation (CIP) is a unique property of cellular communication that enables cells to stop growing 23 YAP/TAZ at high cell density (Dominguez-Calderon et al., 2016) . However, the biochemical mechanism by which 24 ZO-2 regulates the distribution of YAP and TAZ remains elusive.
26
Here, we investigated the function of ZO-2 in relocating YAP from the nucleus to the cytoplasm, as cells grew to 27 confluence and form tight junctions. Independent of the physical constraint of cell shape, apical-basal polarity, 28 and E-cadherin-based cell-cell cohesion, ZO-2 stimulated LATS1-dependent phosphorylation of YAP, thereby 29 promoting the retention of YAP in the cytoplasm in densely cultured cells. ZO-2 was essential for the recruitment 30 of LATS1 to tight junctions as cells grew to confluence. The localization of LATS1 kinase at tight junctions was 31 associated with the accumulation of phosphorylated YAP in the cytoplasm. ZO-2 acted as a scaffold to foster a 32 tripartite complex with LATS1 and YAP, leading to activation of LATS1 by angiomotin and NF2 once the complex 33 was recruited to tight junctions. ZO-2 also inhibited proteasome-mediated degradation of LATS1. These findings delineate a novel mechanism governing CIP, in which ZO-2 utilizes the status of cell-cell cohesion to control the 1 phosphorylation status of YAP by LATS1 in the cytoplasm. As cell density increases, the shape of cellular architectures changes because of physical constraints from 5 neighbouring cells, together with the establishment of apical-basal polarity, cell-cell cohesions, and 6 reorganization of cellular cytoskeletons. To determine the contribution of external physical constraints on the 7 translocation of YAP from the nucleus to the cytoplasm as cells grow to confluence, we prepared two distinct 8 conditions of MDCK cells at high cell density ( Fig. 1 A) . In one condition, cells grew to reach confluence over 3 9 days, permitting them to fully polarize gp135/podocalyxin at the apical cortex and E-cadherin at the lateral cell-10 cell junctions (Fig. 1, B and C). In the second condition, cells grew to confluence within 24 hours of seeding, 11 which only permitted the establishment of premature apical-basal polarization and weak accumulation of E-12 cadherin at the cell-cell junctions (Fig. 1, B and C). YAP was exclusively localized to nuclei in cells grown under 13 sparse cell density condition (Fig. 1, B -D) . At high cell density, YAP was predominantly localized to the cytoplasm 14 in fully-polarized cells, but was seen both in the cytoplasm and in the nucleus in partially polarized cells ( Fig. 1b-15 d). Consistent with the distribution of YAP, the amount of phosphorylated YAP (at the S127 residue) and LATS1
16
(at the S909 residue) in the cytoplasm were higher in fully polarized cells than in partially polarized cells ( Fig. 1 , E 17 and F). By contrast, the phosphorylation of MST-1 and MST-2 (at the T183 and T180 residues, respectively) was 18 unaffected by the degree of cell polarization (Fig. 1 F) . Inhibition of LATS1 and YAP did not affect the distribution 19 of gp135 at the apical cortex and E-cadherin at the lateral junctions ( Fig. S1 ), indicating that the Hippo pathway 20 itself was dispensable for the establishment of apical-basal polarity. Collectively, these results suggest that, 21 independent of external physical constraints of cellular architectures, the maturation of cell-cell cohesion is likely 22 to be associated with the activation of LATS1 kinase and the phosphorylation and efficient translocation of YAP 23 from the nucleus to the cytoplasm. 24 25 ZO-2 is required for efficient phosphorylation and exclusion of YAP from the nucleus at high cell density 26 Next, we investigated the role of ZO-2 in the relocation of YAP from the nucleus to the cytoplasm at high cell 27 density. Like YAP, ZO-2 predominantly accumulated in the nucleus at low cell density, and in the cytoplasm and 28 at the tight junctions at high cell density (Fig. 2 A) . The translocation kinetics of ZO-2 and YAP were strongly 29 correlated ( Fig. 2 A) , suggesting a putative role of ZO-2 in exclusion of YAP from the nucleus or in retention of 30 YAP in the cytoplasm. To test these possibilities, we examined the distribution of YAP in ZO-2 depleted cells.
31
Knockdown of ZO-2 using short-hairpin RNA (shRNA) did not alter the retention of YAP in the nucleus at lower 32 cell density (Fig. S2 ). ZO-2 depleted cells established apical enrichment of gp135 and lateral enrichment of E-33 cadherin and ZO-1 (Fig. 2 B) but retained a substantial amount of YAP in the nuclei at confluent cell density even three days after seeding (Fig. 2, B -D) . In these confluent cells, ZO-2 knockdown did not affect phosphorylation of 1 MST1 and MST2 kinases, but significantly reduced YAP phosphorylation at the S127 residue and marginally 2 reduced LATS1 phosphorylation at the S909 residue (Fig. 2 E) . Notably, the amount of LATS1 protein was 3 significantly reduced in ZO-2 depleted cells (Figs. 2 E and 3 A) . Expression of ZO-2 transgene restored the levels 4 of LATS1 protein (Fig. 3 B) . Based on these results, we conclude that ZO-2 is essential for several events that 5 lead to effective translocation of YAP in fully polarized cells at high density, including the maintenance of the 6 LATS1 protein and the increase in the levels of S909-phosphorylated LATS1 and S127-phosphorylated YAP. 7 8 ZO-2 is essential to prevent proteasome-mediated degradation of LATS1 at high cell density 9 ZO-2 may stimulate the nucleus-to-cytoplasm translocation of YAP by maintaining the amount of LATS1 protein 10 as cells grow to confluence. To test this possibility, we investigated whether a higher level of LATS1 protein was 11 sufficient to induce the effective translocation of YAP in ZO-2 depleted cells at high density. Real-time 12 quantitative PCR analysis showed that the level of Lats1 mRNA was unaffected by ZO-2 knockdown ( Fig. 3 C) .
13
Given that LATS1 can be poly-ubiquitinated by the ubiquitin ligase CRL4 DCAF1 (Li et al., 2014) , we hypothesized 14 that ZO-2 could inhibit ubiquitination and consequently prevent degradation of LATS1 protein. Immunoblotting 15 against the poly-ubiquitination moiety revealed that the immunoprecipitated LATS1 was poly-ubiquitinated at high 16 cell density (Fig. 3 D) . The level of poly-ubiquitinated LATS1 in ZO-2 depleted cells was significantly higher than 17 that in control cells (Fig. 3 D) and returned to a normal level upon re-introduction of ZO-2 by a transgene (Fig. 3 18 D). The reduction in LATS1 protein levels in ZO-2 depleted cells was suppressed either by over-expression of a 19 dominant-negative ubiquitin allele, Ubi-K0 ( Fig. 3 E) or by treatment with a proteasome inhibitor, MG132 ( Fig. 3 20 F). Together, these data suggest that ZO-2 is essential for the maintenance of LATS1 protein through preventing 21 it from ubiquitin-dependent degradation by the proteasome (Fig. 3 G) . We then tested whether prevention of 22 LATS1 protein degradation could restore the level of YAP phosphorylation and the relocation of YAP in ZO-2 23 depleted cells at high density. Although treatment with MG132 restored the levels of LATS1 and its 24 phosphorylation at S909, it did not restore the phosphorylation of YAP at the S127 residue and did not change 25 the distribution of YAP in the nucleus and in the cytoplasm in ZO-2 depleted cells (Fig. 3 , H and I). These data 26 indicated that the recovery of LATS1 protein levels alone was insufficient for effective phosphorylation of YAP 27 and its redistribution at high cell density.
29
The exit of ZO-2 from the nucleus stimulates efficient nuclear exit of YAP
30
To test the second possibility whereby the nucleus-to-cytoplasm relocation of ZO-2 could stimulate YAP to exit 31 from the nucleus and/or retain it in the cytoplasm, we sought to create a mutant ZO-2, which would consistently 32 localize to the nucleus irrespective of cell density conditions. ZO-2 contains three nuclear export signal (NES) 33 sequences ( Fig. S3 A) . A truncated form of ZO-2 (1-590 amino acids), which contained three PDZ domains and lacked the second and the third NESs, predominantly localized in the nucleus at both low and high cell densities 1 ( Fig. S3 B) . Overexpression of ZO-2[1-590 aa] significantly increased the amount of nuclear YAP at high cell 2 density ( Fig. S3 B) . Given the physical interaction between ZO-2 and YAP (Oka et al., 2010) , these results 3 suggest that the relocation of ZO-2 to the cytoplasm and subsequent reduction in nuclear ZO-2 concentration 4 stimulates the translocation of YAP from the nucleus to the cytoplasm. To test the third possibility whereby ZO-2 could enable LATS1 to effectively interact with and phosphorylate YAP,
8
we examined if ZO-2 enhanced the interaction between LATS1 and YAP in cells at high density.
9
Immunoprecipitation assays revealed that endogenous ZO-2 was associated with both LATS1 and YAP ( Fig. 4, A   10 and B). The interactions among LATS1, ZO-2, and YAP were further enhanced as the cells grew to confluence 11 (Fig. 4, A and B) . Depletion of ZO-2 significantly reduced an interaction between LATS1 and YAP ( Fig. 4 with LATS1 ( Fig. 4 , D and E) and did not stimulate the interaction between LATS1 and YAP ( Fig. 4 F) . A mutant 15 form of LATS1 containing mutations in its SH3-domain-binding motifs was unable to bind to G and 16 H). LATS1 was detected in FLAG-YAP immunoprecipitates from ZO-2 depleted cells after a transgene that 17 expressed ZO-2 but not ZO-2[DSH3] was re-introduced ( Fig. 4 F) , indicating that an interaction between ZO-2 18 and LATS1 is essential for LATS1 to efficiently bind to YAP. These results indicate that ZO-2 utilizes its SH3
19
domain to bind to LATS1 and enhance the interaction between LATS1 and YAP.
21
ZO-2 can interact not only with LATS1 but also with YAP through its first PDZ domain (Oka et al., 2010) . We then 22 hypothesized that ZO-2 could serve as a scaffold to facilitate the interaction between LATS1 and YAP. A weak 23 interaction was detected between YAP and LATS1 using FLAG-YAP immunoprecipitates when ZO-2 was 24 severely depleted or at low levels ( Fig. 4 I) . Increasing levels of ZO-2 led to a significant, corresponding increase 25 in the amount of LATS1 co-immunoprecipitated with FLAG-YAP, and this reached a maximal level with 1mg HA-26 ZO2, before falling back down to a basal level as HA-ZO-2 concentration was increased ( Fig. 4 I) . These results
27
imply that an optimal level of ZO-2 is required for the efficient formation of a LATS1-ZO-2-YAP complex. When
28
ZO-2 was highly saturated, a ZO-2-YAP complex (and probably a LATS-1-ZO-2 complex) was predominantly 29 observed at the expense of a LATS1-ZO-2-YAP complex. Based on these biochemical assays, we conclude 30 that ZO-2 serves as a scaffold that enables LATS1 to interact with YAP in a tripartite complex ( Fig. 4 J) .
32
ZO-2 is essential for the recruitment of S909-phosphorylated LATS1 to tight junctions
To further investigate where the LATS1-ZO-2-YAP complex stimulates effective interaction between LATS1 and 1 YAP in cells at high density, we observed the distribution of LATS1 phosphorylated at the S909 residue.
2
Immunostaining revealed the presence of S909-phosphorylated LATS1 in the nucleus at lower cell density and at 3 the apical cell-cell junctions at higher cell density ( Fig. 5 A) . In ZO-2 depleted cells, this junctional distribution of 4 S909-phosphorylated LATS1 was abolished ( Fig. 5 A) , and was restored by re-introduction of ZO-2 by a 5 transgene ( Fig. 5 B) . Consistent with a role of ZO-2 in the recruitment of S909-phosphorylated LATS1 to apical 6 junctions, S909-phosphorylated LATS1 was detected in the ZO-2 immunoprecipitates from cells at high density 7 ( 2-FRB and either FKBP-Amot or FKBP-NF2, the levels of phosphorylated LATS1 (S909) was lower in the 34 absence of AP21967, but was significantly increased after the addition of AP21967 (Fig. S5 ). The levels of 1 phosphorylated YAP (S127) showed only marginal increase 30 minutes after AP21967 treatment ( Fig. S5 ).
Taking these results together, we conclude that tight junctions serve as a platform for stimulating interactions 3 between the LATS1-ZO-2-YAP complex with angiomotin and NF2, leading to effective activation of LATS1 to 4 phosphorylate YAP and retention of YAP in the cytoplasm.
6
Discussion 1 2 Contact inhibition of proliferation (CIP) has been recognized as a primary mechanism for the regulation of cell 3 and tissue growth, which is controlled by the subcellular distribution of YAP (Gumbiner and Kim, 2014;  4 McClatchey and Yap, 2012) . In this study, we presented evidence that tight junctions serve as a platform that 5 transduces the status of cell-cell cohesion into effective phosphorylation and retention of YAP in the cytoplasm.
Our findings reveal that the tight junction protein, ZO-2, stimulates LATS1-dependent phosphorylation of YAP in 7 cells at high density in several steps. First, ZO-2 undergoes translocation from the nucleus to the cytoplasm, 
We also demonstrated that ZO-2 maintained the level of LATS1 protein during high cell density by protecting it 7 from proteasome-mediated degradation. Our data showed that the SH3 domain of ZO-2 was indispensable for 8 the protection of LATS1, suggesting that a physical interaction between ZO-2 and LATS1 prevented the poly-9 ubiquitination of LATS1. However, the recovery of LATS1 protein level and its phosphorylation by proteasome The authors declare no competing financial interests. screened for stable cell lines that consistently exhibited a reduction in the level of target proteins. Immunoblotting 10 analyses were used to quantify the levels of protein levels in extracts from cells treated with or without shRNA.
11
The primers used in this study for creating the shRNA constructs are shown in Table S2 . 
22
Cell extracts were centrifuged at 21,000 x g for 10 minutes. Supernatants were incubated with primary antibodies 23 overnight at 4 ºC, then mixed with Protein A/G PLUS-Agarose (Santa Cruz Biotechnology) for 2 hours at 4 ºC.
24
The agarose beads were washed three times with RIPA buffer, and treated with 6X protein SDS loading dye at 25 85 °C for 6 minutes. FLAG fusion protein was immunoprecipitated with anti-FLAG antibody conjugated with M2 26 beads (Sigma-Aldrich). 1 Fisher Scientific), and 10 mM each of the forward and reverse primers. PCR was performed using the following 2 conditions: initial denaturation at 95 °C for 2 minutes, followed by 35 cycles of denaturation at 95 °C for 45 3 seconds, primer annealing at 55 °C for 45 seconds and elongation at 72 °C for 1 minute, and lastly a final 4 elongation at 72 °C for 10 minutes.
6
RT-qPCR was performed using 80-140 ng cDNA, SsoFast TM EvaGreen ® Supermix (Bio-Rad), and 500 nM each 7 of the forward and reverse primers. This reaction mixture was then subjected to an initial denaturation at 95 °C 8 for 30 seconds, followed by 50 cycles of reactions each consisted of denaturation at 95 °C for 5 seconds and 9 combined annealing and extension at 60 °C for 5 seconds. Melt curves were generated at a Tm ranging from 10 65 °C to 95 °C for 5 seconds at each 0.5 °C increment. 
4
Cells were seeded at different cell densities to reach a sparse, semi-confluent, or confluent cell density 24 hours 5 after seeding. Cells were also seeded at distinct cell densities to achieve a semi-confluent or confluent cell 6 density 48 or 72 hours after seeding, respectively. 
11
(E) Representative immunoblotting images for ZO-2, LATS1, S909-phosphorylated LATS1 (pLATS S909), YAP, 12 S127-phosphorylated YAP (pYAP S127), MST1, T183/T180-phosphorylated MST1/2 (pMST1 T183 / pMST2 13 T180), GAPDH, histone H3 (H3), and S10-phosphorylated histone H3 (pH3 S10) from extracts of control cells 
